HIMS Today - Jul 11: Amazon's GLP-1 Moves Impact Stock

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

HIMS Today - Jul 11: Amazon's GLP-1 Moves Impact Stock

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey here, your friendly neighborhood investor. Been in the game for a while and today we’re talking about Hims & Hers, ticker HIMS. Spoiler alert: it was a red day, down about 3%. Ouch!

So, what went down? HIMS got smoked today, dropping a solid chunk of change. The stock dipped after Amazon decided to ramp up its game in the GLP-1 space, which is a big deal. These GLP-1 drugs, like Ozempic, have been the hot topic lately, and now with Amazon stepping in, it’s shaking things up a bit for HIMS.

Now, why did this matter? Well, investors got a little spooked. Amazon’s entry into this market means more competition, and that can make people nervous about HIMS’ growth prospects. It’s like when your favorite pizza place suddenly has a new rival across the street – you start wondering if they’ll still get your business. Plus, Truist put a hold on HIMS, giving it a $23 target price, which isn’t exactly a vote of confidence. Combine that with some chatter about valuation concerns, and you’ve got a recipe for a sell-off.

And here’s a fun fact to keep in mind: there’s been a lot of buzz around AI healthcare bets as earnings season approaches. That could shake things up for HIMS, too, especially with all the focus on tech in healthcare lately.

So yeah, today was a bit rough for Hims & Hers. But hey, that’s how the market rolls sometimes. Just remember, this is all for info and entertainment. No financial advice here, just a friendly chat about stocks. Catch you later!

まだレビューはありません